. 2019 Jul 29;18(2):585–595. doi: 10.1007/s40200-019-00423-0

Table 3.

The assess of contribution one by one trials in association between alpha-lipoic acid supplementation and fasting glucose and lipid profiles using sensitivity analysis

Variable	Pre-sensitivity analysis			Upper & lower of effect size	Post-sensitivity analysis
Variable	No. of studies included	Pooled WMD (random effect)	95% CI	Upper & lower of effect size	Pooled WMD (random effect)	95% CI	Excluded studies
Glucose	3	−36.93	−65.58, −8.28	Upper	−38.26	−84.05, 7.50	Oprea
Glucose	3	−36.93	−65.58, −8.28	Lower	−49.66	−75.95, −23.38	Mohammadi 2018
Triglycerides	4	−7.45	−51.35, 36.45	Upper	12.86	−22.55, 48.28	Zhao
Triglycerides	4	−7.45	−51.35, 36.45	Lower	−22.29	−74.49, 29.91	Manolescu
Total cholesterol	4	−23.23	−48.07, 1.62	Upper	−13.51	−27.64, 0.61	Zhao
Total cholesterol	4	−23.23	−48.07, 1.62	Lower	−27.99	−56.13, 0.14	Oprea
LDL-cholesterol	4	−10.46	−21.01, 0.09	Upper	−5.49	−21.44, 10.44	Mohammadi 2017
LDL-cholesterol	4	−10.46	−21.01, 0.09	Lower	−13.65	−25.09, −2.21	Manolescu
HDL-cholesterol	3	−3.02	−20.18, 14.14	Upper	0.65	−20.35, 21.66	Manolescu
				Lower	−11.39	−21.77, −1.02	Mohammadi 2017